Mitchell Mathis
Impact in
-
- Tryptophan and brain disorders
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
Papers in ⓘ
-
- Schizophrenia research and treatment 6
- Attention Deficit Hyperactivity Disorder 1
-
- Pharmaceutical studies and practices 6
- Co-authors
- Thomas Pohlmann (1 shared paper)Peiling Yang (3 shared papers)Ellis F. Unger (3 shared papers)Tiffany Farchione (8 shared papers)Thomas Laughren (3 shared papers)Ni A. Khin (2 shared papers)Yeh‐Fong Chen (1 shared paper)Paul A. David (1 shared paper)
- Journals
- The Journal of Clinical Psychiatry (7 papers)The Journal of Clinical Pharmacology (1 paper)JAMA Psychiatry (1 paper)New England Journal of Medicine (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesThailandIndia
In The Last Decade
Mitchell Mathis
15 papers receiving 284 citations
Peers
Comparison fields: 5 of 72
- Biological Psychiatry 24
- Psychiatry and Mental health 114
- Pharmacology 105
- Experimental and Cognitive Psychology 53
- Pharmacology 20
Countries citing papers authored by Mitchell Mathis
This map shows the geographic impact of Mitchell Mathis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Mathis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Mathis more than expected).
Fields of papers citing papers by Mitchell Mathis
This network shows the impact of papers produced by Mitchell Mathis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Mathis. The network helps show where Mitchell Mathis may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell Mathis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 88 | |
| 2 | 2017 | 29 | |
| 3 | 2014 | 26 | |
| 4 | 2012 | 26 | |
| 5 | 2014 | 26 | |
| 6 | 2020 | 19 | |
| 7 | 2017 | 17 | |
| 8 | 2015 | 14 | |
| 9 | 2020 | 12 | |
| 10 | 2017 | 11 | |
| 11 | 2019 | 8 | |
| 12 | 2020 | 7 | |
| 13 | 2018 | 4 | |
| 14 | 2013 | 4 | |
| 15 | 2020 | 1 |
About Mitchell Mathis
Mitchell Mathis is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Statistics and Probability, Economics and Econometrics and Experimental and Cognitive Psychology, having authored 15 papers that have together received 292 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical studies and practices (6 papers), Schizophrenia research and treatment (6 papers), Treatment of Major Depression (2 papers), Statistical Methods in Clinical Trials (2 papers), Attention Deficit Hyperactivity Disorder (1 paper), Metabolism and Genetic Disorders (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Biological Psychiatry (24 citations), Psychiatry and Mental health (114 citations), Pharmacology (105 citations), Experimental and Cognitive Psychology (53 citations) and Pharmacology (20 citations). Mitchell Mathis has collaborated with scholars based in United States, Thailand and India. Frequent co-authors include Thomas Pohlmann, Peiling Yang, Ellis F. Unger, Tiffany Farchione, Thomas Laughren, Ni A. Khin, Yeh‐Fong Chen, Paul A. David, Ramana Uppoor and Robert J. Temple. Their work appears in journals such as The Journal of Clinical Psychiatry, The Journal of Clinical Pharmacology, JAMA Psychiatry, New England Journal of Medicine and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.